Email
IZ Express #1,803: Second measles death, CDC posts 17 revised VISs, and more
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,803: Second measles death, CDC posts 17 revised VISs, and more |
| Date | March 12, 2025 10:48 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,803: March 12, 2025
Top Stories
* CDC issues Health Alert Network (HAN) Health Advisory on expanding measles outbreak in the United States
* Second U.S. measles death announced; prepare your team with resources to educate patients, recognize measles, and vaccinate
* CDC posts revisions to 17 VISs in compliance with Presidential Executive Orders; check that your VIS collection is current
* Immunize.org reviews, updates “Ask the Experts: Administering Vaccines,” web section
* National Infant Immunization Week is April 21–28; prepare your promotion activities with CDC’s digital media toolkit
* Influenza remains at epidemic levels across the country; vaccination protects
* Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 587 institutions, including one new honoree
* How to counsel a healthy adult in their 60s about RSV vaccine: Watch the 2-minute answer, part of the Ask the Experts Video Series on YouTube.
* Vaccines in the news
Immunize.org Website and Clinical Resources
* Recap: Immunize.org updates its “Standing Orders for Administering Recombinant Zoster Vaccine (Shingrix) to Adults” template
Featured Resources
* Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
* Needle anxiety is common at any age. Use Immunize.org’s clinical resources to offer a positive vaccination experience.
* Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations
* While supplies last, order laminated 2025 U.S. immunization schedule booklets from Immunize.org
* Help Immunize.org reach more vaccinators through your social media networks. Follow us and share our posts on Facebook, Instagram, and LinkedIn!
Global News
* “Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater—Five European Countries, September–December 2024” published in MMWR
Upcoming Events
* Today and tomorrow: Questions about our website? Register for Immunize.org Website Office Hours March 12 at 4:00 p.m. (ET) or March 13 at 12:00 p.m. (ET). Previously recorded sessions available online.
* Virtual: Clinical Care Options offers webinar titled “Addressing Key Challenges to RSV Vaccination in Post-Acute and Long-Term Care” on March 13 at 10:00 a.m. (ET); CE credit available
------------------------------------------------------------
Top Stories
------------------------------------------------------------
CDC issues Health Alert Network (HAN) Health Advisory on expanding measles outbreak in the United States
On March 7, CDC issued a Health Alert Network (HAN) ([link removed]) Health Advisory: Expanding Measles Outbreak in the United States and Guidance for the Upcoming Travel Season ([link removed](General%20Public)&deliveryName=USCDC_486-DM145549). CDC issued this HAN to notify clinicians, public health officials, and potential travelers about a measles outbreak that originated in Texas and New Mexico and offer guidance for prevention and monitoring. A portion of the summary of the HAN appears below.
With spring and summer travel season approaching in the United States, CDC emphasizes the important role that clinicians and public health officials play in preventing the spread of measles through vaccination. They should be vigilant for cases of febrile rash illness that meet the measles case definition ([link removed]) particularly in unvaccinated persons, and share effective measles prevention strategies, including vaccination guidance for international travelers.
To prevent measles infection and spread from imported cases, all U.S. residents should be up to date on their MMR vaccinations, especially before traveling internationally, regardless of the destination.
------------------------------------------------------------
Second U.S. measles death announced; prepare your team with resources to educate patients, recognize measles, and vaccinate
The New Mexico Department of Health announced on March 6 the measles-associated death of an unvaccinated adult ([link removed]) who did not seek medical attention before death. This is the second measles death in 2025. Before 2025, the most recent measles death in the United States occurred in 2015. As of March 6, 222 cases of measles had been reported in 2025 in 12 jurisdictions ([link removed]): Alaska, California, Florida, Georgia, Kentucky, New Jersey, New Mexico, New York City, Pennsylvania, Rhode Island, Texas, and Washington. Most of these cases (198), including both reported deaths, are associated with the outbreak that began in Gaines County, Texas, near Lubbock.
Now is the time to ensure your team is prepared to educate your patients and the public about measles and measles vaccination, to recognize and respond to a suspected measles case, and to properly administer MMR to children and adults. Start with the Immunize.org resources compiled at our Vaccines A–Z: Measles ([link removed]) page.
Our standing orders template for adults ([link removed]) was recently edited to clarify the statement that people born in any country (not just the United States) before 1957 are generally presumed to be immune to measles, mumps, and rubella, and do not need MMR. The exception is those who work in a healthcare setting where a stricter standard of proof of immunity applies. Both adult and child MMR standing orders templates ([link removed]) were also updated to correct URLs that have changed on the CDC website.
Note that because our standing orders template addresses prevention of measles, mumps, and rubella with MMR vaccination, it does not reference evaluating the history of the ineffective, inactivated measles vaccine administered to some people between 1963 and 1967, which was never combined with mumps and rubella vaccines.
Below are listed helpful measles information from trusted partners you may also wish to bookmark for reference in the months ahead:
For Clinicians:
* CDC: Measles (Rubeola) ([link removed]) main page
* CDC: Measles Vaccine Recommendations ([link removed]) main page
* American Academy of Pediatrics (AAP): Patient Care Measles ([link removed]) main page
* NFID: Measles ([link removed]) main page
For Patients and the Public:
* CDC: Measles Vaccination ([link removed]) main page
* CHOP Vaccine Education Center: Measles, Mumps and Rubella (MMR): The Diseases & Vaccines ([link removed]) main page
* AAP: How to Protect Your Children During a Measles Outbreak ([link removed]) main page
* Vaccinate Your Family: Vaccines & Diseases: Measles ([link removed]) main page
* Voices for Vaccines: Measles, Mumps, and Rubella (MMR) Vaccine ([link removed]) main page
------------------------------------------------------------
CDC posts revisions to 17 VISs in compliance with Presidential Executive Orders; check that your VIS collection is current
CDC recently posted revisions of 17 VISs, dated January 31, 2025, on its Current VISs ([link removed]) web page. The revisions comply with the January 20, 2025, Presidential Executive Order: Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government ([link removed]). Each of these VISs was changed so that the words "women," "woman," and "she" replace the words “persons, “person,” and “they” when referring to pregnancy or breastfeeding. Users will also note that the VISs have a new CDC logo.
Web links to the revised VISs are shown below.
Cholera ([link removed])
Influenza, live ([link removed])
Polio ([link removed])
COVID-19 ([link removed])
Influenza, recombinant ([link removed])
RSV ([link removed])
Dengue ([link removed])
MMR ([link removed])
Smallpox/Monkeypox ([link removed])
Ebola ([link removed])
MMRV ([link removed]) Tdap ([link removed])
Hepatitis A ([link removed]) Meningococcal AWCY ([link removed])
Varicella ([link removed])
Hepatitis B ([link removed]) Meningococcal B ([link removed])
Each revised VIS is posted at Immunize.org ([link removed]) to help you provide current VISs to all your patients before vaccinating them. Federal law allows up to 6 months for a new VIS to be used. For more on this, see You Must Provide Patients with Vaccine Information Statements (VISs) – It’s Federal Law! ([link removed])
Dates of Current Vaccine Information Statements (VISs) ([link removed]) is another useful document to help you ensure that you are distributing the most recent VISs.
You can use Immunize.org’s clinical resources (created in 2024) with our own QR code links to VISs. These codes will always take you to the current CDC VIS:
* QR Code Links to All Vaccine Information Statements (VISs) ([link removed])
* QR Code Links to Routinely Recommended Vaccine Information Statements (VISs) ([link removed])
* QR Code Links to Vaccine Information Statement (VIS) Translations: Influenza (Flu) Vaccine (Inactivated or Recombinant) ([link removed])
Translations of the newly revised VISs are not available. When a recipient needs a translation, provide the out-of-date translation along with the current federal VIS in English.
------------------------------------------------------------
Immunize.org reviews, updates “Ask the Experts: Administering Vaccines,” web section
Immunize.org reviewed and updated the contents of its Ask the Experts: Administering Vaccines ([link removed]) web page. Links to CDC resources were updated and content concerning new vaccines added, as needed.
Immunize.org's Ask the Experts ([link removed]) main page leads you to 30 distinct web pages on dozens of topics with more than 1,300 common or challenging questions and answers (Q&As) about vaccines and their administration. Immunize.org's team of experts includes Kelly L. Moore, MD, MPH (team lead); Carolyn B. Bridges, MD, FACP; Iyabode Beysolow, MD, MPH; and Jane R. Zucker, MD, MSc.
Related Links
* Immunize.org: Ask the Experts: Administering Vaccines ([link removed]) web page
* Immunize.org: Ask the Experts ([link removed]) main page to access more than 1,300 questions and answers
------------------------------------------------------------
National Infant Immunization Week is April 21–28; prepare your promotion activities with CDC’s digital media toolkit
National Infant Immunization Week (NIIW) ([link removed]), April 21–28, highlights the importance of protecting infants from vaccine-preventable diseases and celebrates the achievements of immunization partners. Since 1994, hundreds of communities have joined together during NIIW to celebrate the crucial role vaccination plays in protecting our children, communities, and public health.
CDC and the American Academy of Pediatrics recommend that children stay on track with their well-child appointments and routine vaccinations. Completing the recommended vaccinations by age 2 years is the best way to protect young children from 15 potentially life-threatening diseases. In light of the recent measles outbreaks and the challenges of the pandemic years, these messages are more important than ever for families to hear.
CDC makes it simple to plan your NIIW activities by using their promotional materials ([link removed]) including English and Spanish logos, sample social media content, social graphics, and key messages. Please share your posts using the hashtag #ivax2protect. Find more actionable strategies, resources, and data ([link removed]) to support getting people of all ages on-schedule with their routine immunizations.
Related Links
* CDC: National Infant Immunization Week (NIIW) ([link removed]) main page
* CDC: Promotional Materials ([link removed]) main page
* CDC: Routine Immunizations on Schedule for Everyone (RISE) ([link removed]) main page
* Immunize.org: Parent Handouts ([link removed]) main page
------------------------------------------------------------
Influenza remains at epidemic levels across the country; vaccination protects
For week 9, ending March 1, CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]), showed influenza-like illness activity at high to very high levels in 32 of 49 reporting jurisdictions. This season is a high-severity season for people of all ages. During week 9, 4.9% of outpatient visits were for influenza-like illness, well above the epidemic threshold of 3.0% for the fourteenth consecutive week. Sixteen pediatric deaths associated with seasonal influenza virus infection were reported during week 9, bringing the 2024–25 season total to 114 childhood deaths due to influenza.
RESP-NET
Visit the CDC Respiratory Virus Hospitalization Surveillance Network (RESP-NET) ([link removed]) for weekly reports of hospitalizations due to three vaccine-preventable seasonal respiratory viruses: COVID-19, influenza, and RSV. COVID-19 vaccination is recommended for everyone age 6 months and older; RSV vaccination at this point in the season is recommended for certain high-risk adults age 60 through 74 and all adults age 75 years and older. RSV immunization of infants and certain high-risk toddlers with nirsevimab (Beyfortus, Sanofi) is recommended until the end of March.
Influenza Vaccination Dashboard
CDC's Weekly Flu Vaccination Dashboard ([link removed]) shows the latest statistics. Coverage level estimates through February 22, by age, appear below. State-by-state differences in coverage vary widely.
* Age 6 months–17 years: 45.8% (last season at this time: 50.9%)
* Age 18 years and older: 45.2% (last season at this time: 45.5%)
CDC recommends everyone age 6 months and older get annual influenza vaccination. Given the high levels of circulating influenza across the country, vaccination this season remains important for all eligible, unvaccinated people.
Identify pharmacies in your area that may offer influenza and COVID-19 vaccines by entering a zip code in the VaccineFinder on Vaccines.gov ([link removed]) or Vacunas.gov ([link removed]).
Related Links
* CDC: Weekly National Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: RESP-NET ([link removed]) main page
* Immunize.org: free clinical resources and patient handouts related to influenza ([link removed])
* Immunize.org: Vaccines A–Z: Influenza ([link removed]) main page
------------------------------------------------------------
Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 587 institutions, including one new honoree
Immunize.org is pleased to welcome one new institution into its Hepatitis B Birth Dose Honor Roll ([link removed](healthcare)), which now recognizes 587 honorees. The new birthing institution appears below with its reported HepB birth dose coverage rate in parentheses.
* LBJ Tropical Medical Center, Faga’alu, American Samoa (95%)
Please join us in recognizing this honoree with sustained excellence that qualifies for an additional year:
* Oneida Health, Oneida, NY (92%) (9 years)
The Honor Roll includes 587 birthing institutions from 50 states, the District of Columbia, American Samoa, Guam, Puerto Rico, Northern Mariana Islands, and U.S. military hospitals overseas.
The Honor Roll is a key part of Immunize.org’s initiative urging the nation’s hospitals to Give Birth to the End of Hep B ([link removed]) . Hospitals and birthing centers are recognized for attaining high coverage for HepB vaccine at birth and meeting additional criteria. To learn whether your organization qualifies and to access the application form, please see Hepatitis B Birth Dose Honor Roll online ([link removed](healthcare)).
Honorees receive an 8.5" x 11" color certificate suitable for printing and framing. Their acceptance is announced through Immunize.org’s social media channels and to IZ Express’s readers.
Please visit the Hepatitis B Birth Dose Honor Roll web page that lists these institutions and celebrates their vigorous efforts to protect infants from perinatal hepatitis B transmission.
Related Immunize.org Resources
* Give Birth to the End of Hep B ([link removed]) main page
* Fact sheet: Do You Qualify for the Hepatitis B Birth Dose Honor Roll? If So, Apply Today. ([link removed])
* Handout on Immunize.org’s campaign: Give Birth to the End of Hep B ([link removed])
* Hepatitis B Birth Dose Honor Roll ([link removed](healthcare)) web page
------------------------------------------------------------
How to counsel a healthy adult in their 60s about RSV vaccine: Watch the 2-minute answer, part of the Ask the Experts Video Series on YouTube.
This week, our featured episode from the Ask the Experts Video Series discusses how to counsel a healthy adult in their 60s about RSV vaccine ([link removed]). The video explains that healthy adults can wait until age 75 to get an RSV vaccine, with plans to reassess patient needs for RSV vaccination if a high-risk condition emerges before age 75.
The 1-minute video is available on our YouTube channel ([link removed]), along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* Vox: What Was Childhood Like Before Vaccines? ([link removed]) (3/6/25)
* American Medical Association: AMA Urges Public to Get Vaccinated amid Growing Measles Outbreaks ([link removed]) (3/5/25)
* STAT: Former Chairs of the Advisory Committee on Immunization Practices on the Panel’s Role ([link removed]) (3/5/25)
* The Ohio State University: Hidden Dangers and Myths: What You Need to Know About HPV and Cancer ([link removed]) (3/4/25)
* PAHO: Measles Outbreaks in the Americas: PAHO Calls for Strengthened Vaccination and Surveillance ([link removed]) (3/3/25)
* FDA: FDA Plans for Selecting Influenza Virus Strains for Vaccine Composition for the 2025–2026 U.S. Influenza Season ([link removed]) (2/28/25)
------------------------------------------------------------
Immunize.org Website and Clinical Resources
------------------------------------------------------------
Recap: Immunize.org updates its “Standing Orders for Administering Recombinant Zoster Vaccine (Shingrix) to Adults” template
Immunize.org updated its Standing Orders for Administering Recombinant Zoster Vaccine (Shingrix) to Adults ([link removed]) template to update URLs and formatting.
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
Confident healthcare provider recommendations for influenza vaccine are powerfully persuasive. This influenza season has been a tough one. To help you maximize patient protection, Immunize.org, in collaboration with CSL Seqirus, updated the 65+ Flu Defense ([link removed]) website.
This helpful site includes information, tools, and tips for communicating with adults age 65 and older about the scope and severity of influenza. Resources include:
* Influenza in Adults 65+: The Facts ([link removed])
* Influenza Vaccination: Questions Patients Aged 65 and Older Frequently Ask Their HCP ([link removed])
* The Importance of Preventing Influenza and COVID-19 ([link removed])
Older adults are at increased risk of severe influenza, COVID-19, and RSV illness, including hospitalization and death, especially if they are not up to date on these vaccinations. A clinician recommendation is the most important reason why a patient will get vaccinated.
Check out the updated 65+ Flu Defense ([link removed]) website to assist your ongoing efforts in protecting this vulnerable population.
------------------------------------------------------------
Needle anxiety is common at any age. Use Immunize.org’s clinical resources to offer a positive vaccination experience.
In Clinical Resources: Improving the Vaccination Experience ([link removed]), Immunize.org provides print and video tools to create a positive vaccination experience and ease injection anxiety in children and adults. Links to additional resources from trusted partner organizations are also provided.
The web page links to eight printable resources ([link removed]) on addressing vaccination anxiety (four for providers, four for recipients), two in-depth webinars, and six brief videos (listed below). As with all Immunize.org resources, these are free to download, link, copy, and share.
The video topics include:
* How to Administer Multiple Intramuscular Vaccines to Adults During One Visit ([link removed])
* Using Enhanced Screening Checklists for Contraindications to Vaccination ([link removed])
* Addressing Vaccination Anxiety for Infants: Strategies for Vaccine Recipients and Caregivers ([link removed])
* Addressing Vaccination Anxiety: Strategies for Healthcare Professionals ([link removed])
* Fainting Related to Vaccination: What You Need to Know ([link removed])
* Addressing Vaccination Anxiety for Children: Strategies for Vaccine Recipients and Caregivers ([link removed])
Related Link
* Immunize.org: Clinical Resources: Improving the Vaccination Experience ([link removed]) web page
------------------------------------------------------------
Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations
Immunize.org's www.Give2MenACWY.org ([link removed]) website promotes the importance of adolescent vaccination, including the recommended MenACWY vaccine booster dose at age 16. Many teens are behind on vaccines because of the pandemic, so vaccine outreach is more important than ever.
Materials on this colorful website for healthcare professionals incorporate the 2020 ACIP meningococcal vaccine recommendations ([link removed]) and coverage statistics from CDC’s National Immunization Survey–Teen (NIS–Teen). One particularly popular resource on the site is the Algorithm for MenACWY Immunization in Adolescents 11 Through 18 Years of Age ([link removed]).
The website is divided into five easy-to-access sections:
* Vaccinate Teens ([link removed]): Teen vaccination schedules and tips for improving vaccination rates
* Give 2 Doses ([link removed]): Tools to help improve second dose coverage of MenACWY vaccine
* 16-Year-Old Visit ([link removed]): Resources to help providers and patients remember the important vaccines recommended for 16-year-olds
* Tools for Providers ([link removed]): Tools to explain meningococcal ACWY vaccine recommendations and improve coverage for all adolescent vaccines
* Resources ([link removed]): Links to print materials ([link removed]), organizations ([link removed]) involved in adolescent
vaccination, personal stories ([link removed]) about the importance of vaccination, and other resources ([link removed]) of interest
The site also categorizes materials ([link removed]) according to whether they are primarily of interest to providers, to adolescents, or to parents.
Visit Give2MenACWY.org ([link removed]) and enjoy browsing (and deploying) its bountiful resources.
Related Links
* Give2MenACWY.org ([link removed]) website
* Algorithm for MenACWY Immunization in Adolescents 11–18 Years of Age ([link removed])
* MenACWY: You're Not Done If You Give Just One: Give 2 Doses to Strengthen Protection ([link removed])
* Recommending MenACWY: What to Say and How to Say It ([link removed])
* Top 10 Ways to Improve Adolescent Immunization Rates ([link removed])
* Developing an Immunization Culture in Your Office ([link removed])
* Know Your Rates: Measuring Immunization Success in Your Practice ([link removed])
* Dear Colleague Letter: 16-Year-Old Patients: Make Sure They Receive Their Annual Well Visit and Vaccinations ([link removed]), signed by six medical societies
* Ask the Experts: Meningococcal ACWY ([link removed])
------------------------------------------------------------
While supplies last, order laminated 2025 U.S. immunization schedule booklets from Immunize.org
Laminated booklets of the 2025 U.S. child and adolescent immunization schedule ([link removed]) and the 2025 U.S. adult immunization schedule ([link removed]) are available now in the Immunize.org shop.
The schedules are available online as PDFs from CDC ([link removed]) at no cost. Immunize.org’s laminated booklets are ideal for use in any busy healthcare setting where vaccines are given. Features include:
* Durability: Their tough coating can be wiped down, and they can stand up to a year's worth of use.
* Format: Each schedule is produced in an 8.5” X 11” booklet format; with color coding for easy reading, our laminated schedules replicate the original CDC formatting, including all tables and notes. The adult schedule is 16 pages and the child and adolescent schedule is 20 pages.
* Easy access to CDC updates: The CDC online schedule includes an addendum page that will display ACIP’s new recommendations as CDC adopts them during 2025. Each Immunize.org laminated schedule addendum page includes QR codes you can scan to view or print the online addendum page as it is revised.
* Bonus content: Both schedules include a bonus page with Immunize.org’s popular 1-page handout summarizing the dose, route, and needle size recommendations for all vaccines and recipients.
Pricing:
Child and Adolescent Booklets Adult Booklets
1 copy: $10.50 1 copy: $10.00
2–4 copies: $10.00 each 2–4 copies: $9.50 each
5–19 copies: $9.00 each 5–19 copies: $8.50 each
20–99 copies: $8.00 each 20–99 copies: $7.50 each
100–499 copies: $6.50 each 100–499 copies: $6.00 each
500–999 copies: $5.50 each 500–999 copies: $5.00 each
1,000–1,999 copies: $4.50 each 1,000–1,999 copies: $4.00 each
2,000+ copies: $3.75 each 2,000+ copies: $3.25 each
Visit the Shop Immunize.org: Laminated Schedules ([link removed]) web page to view images and order today!
For additional information, call 651-647-9009 or email [email protected].
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
------------------------------------------------------------
Help Immunize.org reach more vaccinators through your social media networks. Follow us and share our posts on Facebook, Instagram, and LinkedIn!
Immunize.org offers a social media program to highlight our educational resources for a new audience of vaccinators. Our social media channels feature our most popular printable resources and Ask the Experts questions, as well as announcements important to frontline vaccinators. Please view and share our newest feature, the Ask the Experts Video Series ([link removed]).
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at Immunize.org ([link removed])
* YouTube at ImmunizeOrg ([link removed])
------------------------------------------------------------
Global News
------------------------------------------------------------
“Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater—Five European Countries, September–December 2024” published in MMWR
CDC published Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater—Five European Countries, September–December 2024 ([link removed]) on March 6 in MMWR. A portion of the summary appears below.
A vaccine-derived poliovirus type 2 (VDPV2) lineage that originated in Nigeria has been detected in 21 other countries on the African continent. . . .
During the weeks ending September 22—December 22, 2024, VDPVs genetically linked to the Nigeria lineage were detected in wastewater samples in 16 cities in five European countries. No human polio cases or poliovirus infections were reported in association with these detections. . . .
Isolations of VDPV2 from wastewater appear to represent importations of the virus into these countries. Continued circulation of VDPV2 in African countries could result in similar importations and potential transmission in susceptible populations outside of Africa. High coverage with poliovirus vaccines is critical to protect against polio disease and prevent establishment of local circulation following poliovirus importation.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* CDC: MMWR main page ([link removed]) providing access to the MMWR family of publications
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today and tomorrow: Questions about our website? Register for Immunize.org Website Office Hours March 12 at 4:00 p.m. (ET) or March 13 at 12:00 p.m. (ET). Previously recorded sessions available online.
To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, March 12 at 4:00 p.m. (ET) ([link removed]) or Thursday, March 13 at 12:00 p.m. (ET) ([link removed]). The same content will be covered in both sessions.
We will open each 45-minute session with a short, live demonstration on navigating the following site content: images, webinars, videos, and social media. You can submit questions when you register or live on Zoom during the session.
Register today for Immunize.org Website Office Hours (content is the same for both):
* Wednesday, March 12 at 4:00 p.m. (ET) ([link removed])
* Thursday, March 13 at 12:00 p.m. (ET) ([link removed])
The archive of previous Website Office Hours content is posted at Immunize.org’s Webinars & Videos ([link removed]) page
Mark your calendar ([link removed]) for future Immunize.org Website Office Hours.
------------------------------------------------------------
Virtual: Clinical Care Options offers webinar titled “Addressing Key Challenges to RSV Vaccination in Post-Acute and Long-Term Care” on March 13 at 10:00 a.m. (ET); CE credit available
Clinical Care Options, in partnership with the Post-Acute and Long-Term Care Medical Association ([link removed]), will host a webinar titled Addressing Key Challenges to RSV Vaccination in Post-Acute and Long-Term Care ([link removed] ), 10:00–4:30 a.m. (ET) on March 13.
Using an interactive, “choose your adventure” format, participants will learn how to overcome challenges to RSV vaccination relevant to their own practice. Presenters include Jewel Mullen, MD, MPH, and Dallas Nelson, MD, FACP. The program is supported by an educational grant from GSK.
There is no fee to attend. CME, CNE, and CPE credit are available.
Register for the webinar ([link removed]).
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer (http:// [link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,803: March 12, 2025
Top Stories
* CDC issues Health Alert Network (HAN) Health Advisory on expanding measles outbreak in the United States
* Second U.S. measles death announced; prepare your team with resources to educate patients, recognize measles, and vaccinate
* CDC posts revisions to 17 VISs in compliance with Presidential Executive Orders; check that your VIS collection is current
* Immunize.org reviews, updates “Ask the Experts: Administering Vaccines,” web section
* National Infant Immunization Week is April 21–28; prepare your promotion activities with CDC’s digital media toolkit
* Influenza remains at epidemic levels across the country; vaccination protects
* Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 587 institutions, including one new honoree
* How to counsel a healthy adult in their 60s about RSV vaccine: Watch the 2-minute answer, part of the Ask the Experts Video Series on YouTube.
* Vaccines in the news
Immunize.org Website and Clinical Resources
* Recap: Immunize.org updates its “Standing Orders for Administering Recombinant Zoster Vaccine (Shingrix) to Adults” template
Featured Resources
* Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
* Needle anxiety is common at any age. Use Immunize.org’s clinical resources to offer a positive vaccination experience.
* Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations
* While supplies last, order laminated 2025 U.S. immunization schedule booklets from Immunize.org
* Help Immunize.org reach more vaccinators through your social media networks. Follow us and share our posts on Facebook, Instagram, and LinkedIn!
Global News
* “Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater—Five European Countries, September–December 2024” published in MMWR
Upcoming Events
* Today and tomorrow: Questions about our website? Register for Immunize.org Website Office Hours March 12 at 4:00 p.m. (ET) or March 13 at 12:00 p.m. (ET). Previously recorded sessions available online.
* Virtual: Clinical Care Options offers webinar titled “Addressing Key Challenges to RSV Vaccination in Post-Acute and Long-Term Care” on March 13 at 10:00 a.m. (ET); CE credit available
------------------------------------------------------------
Top Stories
------------------------------------------------------------
CDC issues Health Alert Network (HAN) Health Advisory on expanding measles outbreak in the United States
On March 7, CDC issued a Health Alert Network (HAN) ([link removed]) Health Advisory: Expanding Measles Outbreak in the United States and Guidance for the Upcoming Travel Season ([link removed](General%20Public)&deliveryName=USCDC_486-DM145549). CDC issued this HAN to notify clinicians, public health officials, and potential travelers about a measles outbreak that originated in Texas and New Mexico and offer guidance for prevention and monitoring. A portion of the summary of the HAN appears below.
With spring and summer travel season approaching in the United States, CDC emphasizes the important role that clinicians and public health officials play in preventing the spread of measles through vaccination. They should be vigilant for cases of febrile rash illness that meet the measles case definition ([link removed]) particularly in unvaccinated persons, and share effective measles prevention strategies, including vaccination guidance for international travelers.
To prevent measles infection and spread from imported cases, all U.S. residents should be up to date on their MMR vaccinations, especially before traveling internationally, regardless of the destination.
------------------------------------------------------------
Second U.S. measles death announced; prepare your team with resources to educate patients, recognize measles, and vaccinate
The New Mexico Department of Health announced on March 6 the measles-associated death of an unvaccinated adult ([link removed]) who did not seek medical attention before death. This is the second measles death in 2025. Before 2025, the most recent measles death in the United States occurred in 2015. As of March 6, 222 cases of measles had been reported in 2025 in 12 jurisdictions ([link removed]): Alaska, California, Florida, Georgia, Kentucky, New Jersey, New Mexico, New York City, Pennsylvania, Rhode Island, Texas, and Washington. Most of these cases (198), including both reported deaths, are associated with the outbreak that began in Gaines County, Texas, near Lubbock.
Now is the time to ensure your team is prepared to educate your patients and the public about measles and measles vaccination, to recognize and respond to a suspected measles case, and to properly administer MMR to children and adults. Start with the Immunize.org resources compiled at our Vaccines A–Z: Measles ([link removed]) page.
Our standing orders template for adults ([link removed]) was recently edited to clarify the statement that people born in any country (not just the United States) before 1957 are generally presumed to be immune to measles, mumps, and rubella, and do not need MMR. The exception is those who work in a healthcare setting where a stricter standard of proof of immunity applies. Both adult and child MMR standing orders templates ([link removed]) were also updated to correct URLs that have changed on the CDC website.
Note that because our standing orders template addresses prevention of measles, mumps, and rubella with MMR vaccination, it does not reference evaluating the history of the ineffective, inactivated measles vaccine administered to some people between 1963 and 1967, which was never combined with mumps and rubella vaccines.
Below are listed helpful measles information from trusted partners you may also wish to bookmark for reference in the months ahead:
For Clinicians:
* CDC: Measles (Rubeola) ([link removed]) main page
* CDC: Measles Vaccine Recommendations ([link removed]) main page
* American Academy of Pediatrics (AAP): Patient Care Measles ([link removed]) main page
* NFID: Measles ([link removed]) main page
For Patients and the Public:
* CDC: Measles Vaccination ([link removed]) main page
* CHOP Vaccine Education Center: Measles, Mumps and Rubella (MMR): The Diseases & Vaccines ([link removed]) main page
* AAP: How to Protect Your Children During a Measles Outbreak ([link removed]) main page
* Vaccinate Your Family: Vaccines & Diseases: Measles ([link removed]) main page
* Voices for Vaccines: Measles, Mumps, and Rubella (MMR) Vaccine ([link removed]) main page
------------------------------------------------------------
CDC posts revisions to 17 VISs in compliance with Presidential Executive Orders; check that your VIS collection is current
CDC recently posted revisions of 17 VISs, dated January 31, 2025, on its Current VISs ([link removed]) web page. The revisions comply with the January 20, 2025, Presidential Executive Order: Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government ([link removed]). Each of these VISs was changed so that the words "women," "woman," and "she" replace the words “persons, “person,” and “they” when referring to pregnancy or breastfeeding. Users will also note that the VISs have a new CDC logo.
Web links to the revised VISs are shown below.
Cholera ([link removed])
Influenza, live ([link removed])
Polio ([link removed])
COVID-19 ([link removed])
Influenza, recombinant ([link removed])
RSV ([link removed])
Dengue ([link removed])
MMR ([link removed])
Smallpox/Monkeypox ([link removed])
Ebola ([link removed])
MMRV ([link removed]) Tdap ([link removed])
Hepatitis A ([link removed]) Meningococcal AWCY ([link removed])
Varicella ([link removed])
Hepatitis B ([link removed]) Meningococcal B ([link removed])
Each revised VIS is posted at Immunize.org ([link removed]) to help you provide current VISs to all your patients before vaccinating them. Federal law allows up to 6 months for a new VIS to be used. For more on this, see You Must Provide Patients with Vaccine Information Statements (VISs) – It’s Federal Law! ([link removed])
Dates of Current Vaccine Information Statements (VISs) ([link removed]) is another useful document to help you ensure that you are distributing the most recent VISs.
You can use Immunize.org’s clinical resources (created in 2024) with our own QR code links to VISs. These codes will always take you to the current CDC VIS:
* QR Code Links to All Vaccine Information Statements (VISs) ([link removed])
* QR Code Links to Routinely Recommended Vaccine Information Statements (VISs) ([link removed])
* QR Code Links to Vaccine Information Statement (VIS) Translations: Influenza (Flu) Vaccine (Inactivated or Recombinant) ([link removed])
Translations of the newly revised VISs are not available. When a recipient needs a translation, provide the out-of-date translation along with the current federal VIS in English.
------------------------------------------------------------
Immunize.org reviews, updates “Ask the Experts: Administering Vaccines,” web section
Immunize.org reviewed and updated the contents of its Ask the Experts: Administering Vaccines ([link removed]) web page. Links to CDC resources were updated and content concerning new vaccines added, as needed.
Immunize.org's Ask the Experts ([link removed]) main page leads you to 30 distinct web pages on dozens of topics with more than 1,300 common or challenging questions and answers (Q&As) about vaccines and their administration. Immunize.org's team of experts includes Kelly L. Moore, MD, MPH (team lead); Carolyn B. Bridges, MD, FACP; Iyabode Beysolow, MD, MPH; and Jane R. Zucker, MD, MSc.
Related Links
* Immunize.org: Ask the Experts: Administering Vaccines ([link removed]) web page
* Immunize.org: Ask the Experts ([link removed]) main page to access more than 1,300 questions and answers
------------------------------------------------------------
National Infant Immunization Week is April 21–28; prepare your promotion activities with CDC’s digital media toolkit
National Infant Immunization Week (NIIW) ([link removed]), April 21–28, highlights the importance of protecting infants from vaccine-preventable diseases and celebrates the achievements of immunization partners. Since 1994, hundreds of communities have joined together during NIIW to celebrate the crucial role vaccination plays in protecting our children, communities, and public health.
CDC and the American Academy of Pediatrics recommend that children stay on track with their well-child appointments and routine vaccinations. Completing the recommended vaccinations by age 2 years is the best way to protect young children from 15 potentially life-threatening diseases. In light of the recent measles outbreaks and the challenges of the pandemic years, these messages are more important than ever for families to hear.
CDC makes it simple to plan your NIIW activities by using their promotional materials ([link removed]) including English and Spanish logos, sample social media content, social graphics, and key messages. Please share your posts using the hashtag #ivax2protect. Find more actionable strategies, resources, and data ([link removed]) to support getting people of all ages on-schedule with their routine immunizations.
Related Links
* CDC: National Infant Immunization Week (NIIW) ([link removed]) main page
* CDC: Promotional Materials ([link removed]) main page
* CDC: Routine Immunizations on Schedule for Everyone (RISE) ([link removed]) main page
* Immunize.org: Parent Handouts ([link removed]) main page
------------------------------------------------------------
Influenza remains at epidemic levels across the country; vaccination protects
For week 9, ending March 1, CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]), showed influenza-like illness activity at high to very high levels in 32 of 49 reporting jurisdictions. This season is a high-severity season for people of all ages. During week 9, 4.9% of outpatient visits were for influenza-like illness, well above the epidemic threshold of 3.0% for the fourteenth consecutive week. Sixteen pediatric deaths associated with seasonal influenza virus infection were reported during week 9, bringing the 2024–25 season total to 114 childhood deaths due to influenza.
RESP-NET
Visit the CDC Respiratory Virus Hospitalization Surveillance Network (RESP-NET) ([link removed]) for weekly reports of hospitalizations due to three vaccine-preventable seasonal respiratory viruses: COVID-19, influenza, and RSV. COVID-19 vaccination is recommended for everyone age 6 months and older; RSV vaccination at this point in the season is recommended for certain high-risk adults age 60 through 74 and all adults age 75 years and older. RSV immunization of infants and certain high-risk toddlers with nirsevimab (Beyfortus, Sanofi) is recommended until the end of March.
Influenza Vaccination Dashboard
CDC's Weekly Flu Vaccination Dashboard ([link removed]) shows the latest statistics. Coverage level estimates through February 22, by age, appear below. State-by-state differences in coverage vary widely.
* Age 6 months–17 years: 45.8% (last season at this time: 50.9%)
* Age 18 years and older: 45.2% (last season at this time: 45.5%)
CDC recommends everyone age 6 months and older get annual influenza vaccination. Given the high levels of circulating influenza across the country, vaccination this season remains important for all eligible, unvaccinated people.
Identify pharmacies in your area that may offer influenza and COVID-19 vaccines by entering a zip code in the VaccineFinder on Vaccines.gov ([link removed]) or Vacunas.gov ([link removed]).
Related Links
* CDC: Weekly National Flu Vaccination Dashboard ([link removed]) main page
* CDC: FluView ([link removed]) main page
* CDC: RESP-NET ([link removed]) main page
* Immunize.org: free clinical resources and patient handouts related to influenza ([link removed])
* Immunize.org: Vaccines A–Z: Influenza ([link removed]) main page
------------------------------------------------------------
Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 587 institutions, including one new honoree
Immunize.org is pleased to welcome one new institution into its Hepatitis B Birth Dose Honor Roll ([link removed](healthcare)), which now recognizes 587 honorees. The new birthing institution appears below with its reported HepB birth dose coverage rate in parentheses.
* LBJ Tropical Medical Center, Faga’alu, American Samoa (95%)
Please join us in recognizing this honoree with sustained excellence that qualifies for an additional year:
* Oneida Health, Oneida, NY (92%) (9 years)
The Honor Roll includes 587 birthing institutions from 50 states, the District of Columbia, American Samoa, Guam, Puerto Rico, Northern Mariana Islands, and U.S. military hospitals overseas.
The Honor Roll is a key part of Immunize.org’s initiative urging the nation’s hospitals to Give Birth to the End of Hep B ([link removed]) . Hospitals and birthing centers are recognized for attaining high coverage for HepB vaccine at birth and meeting additional criteria. To learn whether your organization qualifies and to access the application form, please see Hepatitis B Birth Dose Honor Roll online ([link removed](healthcare)).
Honorees receive an 8.5" x 11" color certificate suitable for printing and framing. Their acceptance is announced through Immunize.org’s social media channels and to IZ Express’s readers.
Please visit the Hepatitis B Birth Dose Honor Roll web page that lists these institutions and celebrates their vigorous efforts to protect infants from perinatal hepatitis B transmission.
Related Immunize.org Resources
* Give Birth to the End of Hep B ([link removed]) main page
* Fact sheet: Do You Qualify for the Hepatitis B Birth Dose Honor Roll? If So, Apply Today. ([link removed])
* Handout on Immunize.org’s campaign: Give Birth to the End of Hep B ([link removed])
* Hepatitis B Birth Dose Honor Roll ([link removed](healthcare)) web page
------------------------------------------------------------
How to counsel a healthy adult in their 60s about RSV vaccine: Watch the 2-minute answer, part of the Ask the Experts Video Series on YouTube.
This week, our featured episode from the Ask the Experts Video Series discusses how to counsel a healthy adult in their 60s about RSV vaccine ([link removed]). The video explains that healthy adults can wait until age 75 to get an RSV vaccine, with plans to reassess patient needs for RSV vaccination if a high-risk condition emerges before age 75.
The 1-minute video is available on our YouTube channel ([link removed]), along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* Vox: What Was Childhood Like Before Vaccines? ([link removed]) (3/6/25)
* American Medical Association: AMA Urges Public to Get Vaccinated amid Growing Measles Outbreaks ([link removed]) (3/5/25)
* STAT: Former Chairs of the Advisory Committee on Immunization Practices on the Panel’s Role ([link removed]) (3/5/25)
* The Ohio State University: Hidden Dangers and Myths: What You Need to Know About HPV and Cancer ([link removed]) (3/4/25)
* PAHO: Measles Outbreaks in the Americas: PAHO Calls for Strengthened Vaccination and Surveillance ([link removed]) (3/3/25)
* FDA: FDA Plans for Selecting Influenza Virus Strains for Vaccine Composition for the 2025–2026 U.S. Influenza Season ([link removed]) (2/28/25)
------------------------------------------------------------
Immunize.org Website and Clinical Resources
------------------------------------------------------------
Recap: Immunize.org updates its “Standing Orders for Administering Recombinant Zoster Vaccine (Shingrix) to Adults” template
Immunize.org updated its Standing Orders for Administering Recombinant Zoster Vaccine (Shingrix) to Adults ([link removed]) template to update URLs and formatting.
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
Confident healthcare provider recommendations for influenza vaccine are powerfully persuasive. This influenza season has been a tough one. To help you maximize patient protection, Immunize.org, in collaboration with CSL Seqirus, updated the 65+ Flu Defense ([link removed]) website.
This helpful site includes information, tools, and tips for communicating with adults age 65 and older about the scope and severity of influenza. Resources include:
* Influenza in Adults 65+: The Facts ([link removed])
* Influenza Vaccination: Questions Patients Aged 65 and Older Frequently Ask Their HCP ([link removed])
* The Importance of Preventing Influenza and COVID-19 ([link removed])
Older adults are at increased risk of severe influenza, COVID-19, and RSV illness, including hospitalization and death, especially if they are not up to date on these vaccinations. A clinician recommendation is the most important reason why a patient will get vaccinated.
Check out the updated 65+ Flu Defense ([link removed]) website to assist your ongoing efforts in protecting this vulnerable population.
------------------------------------------------------------
Needle anxiety is common at any age. Use Immunize.org’s clinical resources to offer a positive vaccination experience.
In Clinical Resources: Improving the Vaccination Experience ([link removed]), Immunize.org provides print and video tools to create a positive vaccination experience and ease injection anxiety in children and adults. Links to additional resources from trusted partner organizations are also provided.
The web page links to eight printable resources ([link removed]) on addressing vaccination anxiety (four for providers, four for recipients), two in-depth webinars, and six brief videos (listed below). As with all Immunize.org resources, these are free to download, link, copy, and share.
The video topics include:
* How to Administer Multiple Intramuscular Vaccines to Adults During One Visit ([link removed])
* Using Enhanced Screening Checklists for Contraindications to Vaccination ([link removed])
* Addressing Vaccination Anxiety for Infants: Strategies for Vaccine Recipients and Caregivers ([link removed])
* Addressing Vaccination Anxiety: Strategies for Healthcare Professionals ([link removed])
* Fainting Related to Vaccination: What You Need to Know ([link removed])
* Addressing Vaccination Anxiety for Children: Strategies for Vaccine Recipients and Caregivers ([link removed])
Related Link
* Immunize.org: Clinical Resources: Improving the Vaccination Experience ([link removed]) web page
------------------------------------------------------------
Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations
Immunize.org's www.Give2MenACWY.org ([link removed]) website promotes the importance of adolescent vaccination, including the recommended MenACWY vaccine booster dose at age 16. Many teens are behind on vaccines because of the pandemic, so vaccine outreach is more important than ever.
Materials on this colorful website for healthcare professionals incorporate the 2020 ACIP meningococcal vaccine recommendations ([link removed]) and coverage statistics from CDC’s National Immunization Survey–Teen (NIS–Teen). One particularly popular resource on the site is the Algorithm for MenACWY Immunization in Adolescents 11 Through 18 Years of Age ([link removed]).
The website is divided into five easy-to-access sections:
* Vaccinate Teens ([link removed]): Teen vaccination schedules and tips for improving vaccination rates
* Give 2 Doses ([link removed]): Tools to help improve second dose coverage of MenACWY vaccine
* 16-Year-Old Visit ([link removed]): Resources to help providers and patients remember the important vaccines recommended for 16-year-olds
* Tools for Providers ([link removed]): Tools to explain meningococcal ACWY vaccine recommendations and improve coverage for all adolescent vaccines
* Resources ([link removed]): Links to print materials ([link removed]), organizations ([link removed]) involved in adolescent
vaccination, personal stories ([link removed]) about the importance of vaccination, and other resources ([link removed]) of interest
The site also categorizes materials ([link removed]) according to whether they are primarily of interest to providers, to adolescents, or to parents.
Visit Give2MenACWY.org ([link removed]) and enjoy browsing (and deploying) its bountiful resources.
Related Links
* Give2MenACWY.org ([link removed]) website
* Algorithm for MenACWY Immunization in Adolescents 11–18 Years of Age ([link removed])
* MenACWY: You're Not Done If You Give Just One: Give 2 Doses to Strengthen Protection ([link removed])
* Recommending MenACWY: What to Say and How to Say It ([link removed])
* Top 10 Ways to Improve Adolescent Immunization Rates ([link removed])
* Developing an Immunization Culture in Your Office ([link removed])
* Know Your Rates: Measuring Immunization Success in Your Practice ([link removed])
* Dear Colleague Letter: 16-Year-Old Patients: Make Sure They Receive Their Annual Well Visit and Vaccinations ([link removed]), signed by six medical societies
* Ask the Experts: Meningococcal ACWY ([link removed])
------------------------------------------------------------
While supplies last, order laminated 2025 U.S. immunization schedule booklets from Immunize.org
Laminated booklets of the 2025 U.S. child and adolescent immunization schedule ([link removed]) and the 2025 U.S. adult immunization schedule ([link removed]) are available now in the Immunize.org shop.
The schedules are available online as PDFs from CDC ([link removed]) at no cost. Immunize.org’s laminated booklets are ideal for use in any busy healthcare setting where vaccines are given. Features include:
* Durability: Their tough coating can be wiped down, and they can stand up to a year's worth of use.
* Format: Each schedule is produced in an 8.5” X 11” booklet format; with color coding for easy reading, our laminated schedules replicate the original CDC formatting, including all tables and notes. The adult schedule is 16 pages and the child and adolescent schedule is 20 pages.
* Easy access to CDC updates: The CDC online schedule includes an addendum page that will display ACIP’s new recommendations as CDC adopts them during 2025. Each Immunize.org laminated schedule addendum page includes QR codes you can scan to view or print the online addendum page as it is revised.
* Bonus content: Both schedules include a bonus page with Immunize.org’s popular 1-page handout summarizing the dose, route, and needle size recommendations for all vaccines and recipients.
Pricing:
Child and Adolescent Booklets Adult Booklets
1 copy: $10.50 1 copy: $10.00
2–4 copies: $10.00 each 2–4 copies: $9.50 each
5–19 copies: $9.00 each 5–19 copies: $8.50 each
20–99 copies: $8.00 each 20–99 copies: $7.50 each
100–499 copies: $6.50 each 100–499 copies: $6.00 each
500–999 copies: $5.50 each 500–999 copies: $5.00 each
1,000–1,999 copies: $4.50 each 1,000–1,999 copies: $4.00 each
2,000+ copies: $3.75 each 2,000+ copies: $3.25 each
Visit the Shop Immunize.org: Laminated Schedules ([link removed]) web page to view images and order today!
For additional information, call 651-647-9009 or email [email protected].
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
------------------------------------------------------------
Help Immunize.org reach more vaccinators through your social media networks. Follow us and share our posts on Facebook, Instagram, and LinkedIn!
Immunize.org offers a social media program to highlight our educational resources for a new audience of vaccinators. Our social media channels feature our most popular printable resources and Ask the Experts questions, as well as announcements important to frontline vaccinators. Please view and share our newest feature, the Ask the Experts Video Series ([link removed]).
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at Immunize.org ([link removed])
* YouTube at ImmunizeOrg ([link removed])
------------------------------------------------------------
Global News
------------------------------------------------------------
“Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater—Five European Countries, September–December 2024” published in MMWR
CDC published Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater—Five European Countries, September–December 2024 ([link removed]) on March 6 in MMWR. A portion of the summary appears below.
A vaccine-derived poliovirus type 2 (VDPV2) lineage that originated in Nigeria has been detected in 21 other countries on the African continent. . . .
During the weeks ending September 22—December 22, 2024, VDPVs genetically linked to the Nigeria lineage were detected in wastewater samples in 16 cities in five European countries. No human polio cases or poliovirus infections were reported in association with these detections. . . .
Isolations of VDPV2 from wastewater appear to represent importations of the virus into these countries. Continued circulation of VDPV2 in African countries could result in similar importations and potential transmission in susceptible populations outside of Africa. High coverage with poliovirus vaccines is critical to protect against polio disease and prevent establishment of local circulation following poliovirus importation.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* CDC: MMWR main page ([link removed]) providing access to the MMWR family of publications
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today and tomorrow: Questions about our website? Register for Immunize.org Website Office Hours March 12 at 4:00 p.m. (ET) or March 13 at 12:00 p.m. (ET). Previously recorded sessions available online.
To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, March 12 at 4:00 p.m. (ET) ([link removed]) or Thursday, March 13 at 12:00 p.m. (ET) ([link removed]). The same content will be covered in both sessions.
We will open each 45-minute session with a short, live demonstration on navigating the following site content: images, webinars, videos, and social media. You can submit questions when you register or live on Zoom during the session.
Register today for Immunize.org Website Office Hours (content is the same for both):
* Wednesday, March 12 at 4:00 p.m. (ET) ([link removed])
* Thursday, March 13 at 12:00 p.m. (ET) ([link removed])
The archive of previous Website Office Hours content is posted at Immunize.org’s Webinars & Videos ([link removed]) page
Mark your calendar ([link removed]) for future Immunize.org Website Office Hours.
------------------------------------------------------------
Virtual: Clinical Care Options offers webinar titled “Addressing Key Challenges to RSV Vaccination in Post-Acute and Long-Term Care” on March 13 at 10:00 a.m. (ET); CE credit available
Clinical Care Options, in partnership with the Post-Acute and Long-Term Care Medical Association ([link removed]), will host a webinar titled Addressing Key Challenges to RSV Vaccination in Post-Acute and Long-Term Care ([link removed] ), 10:00–4:30 a.m. (ET) on March 13.
Using an interactive, “choose your adventure” format, participants will learn how to overcome challenges to RSV vaccination relevant to their own practice. Presenters include Jewel Mullen, MD, MPH, and Dallas Nelson, MD, FACP. The program is supported by an educational grant from GSK.
There is no fee to attend. CME, CNE, and CPE credit are available.
Register for the webinar ([link removed]).
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer (http:// [link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp